Penumbra, Inc. (PEN)
317.73
-0.05
(-0.02%)
USD |
NYSE |
Sep 11, 16:00
317.78
+0.05
(+0.02%)
After-Hours: 20:00
Penumbra Enterprise Value : 12.07B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 12.07B |
| September 10, 2026 | 12.07B |
| September 09, 2026 | 12.14B |
| September 08, 2026 | 12.13B |
| September 04, 2026 | 12.24B |
| September 03, 2026 | 12.20B |
| September 02, 2026 | 12.27B |
| September 01, 2026 | 12.26B |
| August 31, 2026 | 12.28B |
| August 28, 2026 | 12.22B |
| August 27, 2026 | 12.20B |
| August 26, 2026 | 12.28B |
| August 25, 2026 | 12.33B |
| August 24, 2026 | 12.31B |
| August 21, 2026 | 12.36B |
| August 20, 2026 | 12.31B |
| August 19, 2026 | 12.43B |
| August 18, 2026 | 12.35B |
| August 17, 2026 | 12.44B |
| August 14, 2026 | 12.44B |
| August 13, 2026 | 12.42B |
| August 12, 2026 | 12.42B |
| August 11, 2026 | 12.41B |
| August 10, 2026 | 12.39B |
| August 07, 2026 | 12.34B |
| Date | Value |
|---|---|
| August 06, 2026 | 12.35B |
| August 05, 2026 | 12.28B |
| August 04, 2026 | 12.32B |
| August 03, 2026 | 12.28B |
| July 31, 2026 | 12.21B |
| July 30, 2026 | 12.15B |
| July 29, 2026 | 12.16B |
| July 28, 2026 | 12.16B |
| July 27, 2026 | 12.14B |
| July 24, 2026 | 12.11B |
| July 23, 2026 | 12.08B |
| July 22, 2026 | 12.02B |
| July 21, 2026 | 12.06B |
| July 20, 2026 | 12.08B |
| July 17, 2026 | 12.09B |
| July 16, 2026 | 12.14B |
| July 15, 2026 | 12.03B |
| July 14, 2026 | 12.01B |
| July 13, 2026 | 12.12B |
| July 10, 2026 | 12.08B |
| July 09, 2026 | 12.08B |
| July 08, 2026 | 12.05B |
| July 07, 2026 | 12.09B |
| July 06, 2026 | 12.09B |
| July 02, 2026 | 12.10B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp. | 74.40B |
| Globus Medical, Inc. | 9.477B |
| Teleflex, Inc. | 8.108B |
| Abbott Laboratories | 204.07B |
| AngioDynamics, Inc. | 593.86M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 34.81M |
| Revenue (Quarterly) | 390.05M |
| Total Expenses (Quarterly) | 355.24M |
| EPS Diluted (Quarterly) | 0.8797 |
| Gross Profit Margin (Quarterly) | 66.50% |
| Profit Margin (Quarterly) | 8.92% |
| Earnings Yield | 1.28% |
| Operating Earnings Yield | 1.49% |
| Normalized Earnings Yield | 1.282 |